Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652

[1]  W. Gattaz,et al.  Cardiovascular effects of fluvoxamine and maprotiline in depressed patients , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[2]  Cristina Arias,et al.  Spironolactone and Its Main Metabolite, Canrenoic Acid, Block Human Ether-a-Go-Go–Related Gene Channels , 2003, Circulation.

[3]  M. Sanguinetti,et al.  Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Michael C Sanguinetti,et al.  Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel Block* , 2002, The Journal of Biological Chemistry.

[5]  M. Jiang,et al.  Mapping the Binding Site of a Humanether-a-go-go-related Gene-specific Peptide Toxin (ErgTx) to the Channel's Outer Vestibule* , 2002, The Journal of Biological Chemistry.

[6]  Jules C Hancox,et al.  Inhibitory actions of the selective serotonin re‐uptake inhibitor citalopram on HERG and ventricular L‐type calcium currents , 2002, FEBS letters.

[7]  Dierk Thomas,et al.  The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. , 2002, The Journal of pharmacology and experimental therapeutics.

[8]  J. Hancox,et al.  Actions of the selective serotonin re-uptake inhibitor fluvoxamine on HERG-mediated potassium current in a mammalian cell line , 2002 .

[9]  Stanley Nattel,et al.  Dofetilide block involves interactions with open and inactivated states of HERG channels , 2002, Pflügers Archiv - European Journal of Physiology.

[10]  I Kodama,et al.  Open channel block of HERG K(+) channels by vesnarinone. , 2001, Molecular pharmacology.

[11]  B. Lüderitz,et al.  Serum Levels and Cardiovascular Effects of Tricyclic Antidepressants and Selective Serotonin Reuptake Inhibitors in Depressed Patients , 2001, Therapeutic drug monitoring.

[12]  T J Campbell,et al.  HERG K+ channels: friend and foe. , 2001, Trends in pharmacological sciences.

[13]  Y. Sawada,et al.  A comparative pharmacodynamic study of the arrhythmogenicity of antidepressants, fluvoxamine and imipramine, in guinea pigs. , 2001, Biological & pharmaceutical bulletin.

[14]  H. Witchel,et al.  Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide. , 2001, Biochemical and biophysical research communications.

[15]  Jun Chen,et al.  A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Hancox,et al.  Familial And Acquired Long QT Syndrome And The Cardiac Rapid Delayed Rectifier Potassium Current , 2000, Clinical and experimental pharmacology & physiology.

[17]  T J Campbell,et al.  Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel. , 2000, Cardiovascular research.

[18]  A. Camm,et al.  The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. , 2000, Cardiovascular research.

[19]  M. Gralinski.  The assessment of potential for QT interval prolongation with new pharmaceuticals: impact on drug development. , 2000, Journal of pharmacological and toxicological methods.

[20]  H. Duff,et al.  Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites. , 2000, Molecular pharmacology.

[21]  M. Jiang,et al.  Use-dependent 'agonist' effect of azimilide on the HERG channel. , 1999, The Journal of pharmacology and experimental therapeutics.

[22]  S. Viskin.  Long QT syndromes and torsade de pointes , 1999, The Lancet.

[23]  J. Hancox,et al.  Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline , 1999, British journal of pharmacology.

[24]  Cavero,et al.  QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug development. , 1999, Pharmaceutical science & technology today.

[25]  W. Kübler,et al.  Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[26]  A. Brown,et al.  Blockade of HERG and Kv1.5 by ketoconazole. , 1998, The Journal of pharmacology and experimental therapeutics.

[27]  L. Annunziato,et al.  Human ether-a-gogo related gene (HERG) K+ channels as pharmacological targets: present and future implications. , 1998, Biochemical Pharmacology.

[28]  B. Chait,et al.  The structure of the potassium channel: molecular basis of K+ conduction and selectivity. , 1998, Science.

[29]  C. January,et al.  Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. , 1998, Biophysical journal.

[30]  M. Sanguinetti,et al.  Role of delayed rectifier potassium channels in cardiac repolarization and arrhythmias , 1997 .

[31]  J. Henry.  Epidemiology and Relative Toxicity of Antidepressant Drugs in Overdose , 1997, Drug safety.

[32]  D M Roden,et al.  Rapid inactivation determines the rectification and [K+]o dependence of the rapid component of the delayed rectifier K+ current in cardiac cells. , 1997, Circulation research.

[33]  E Wanke,et al.  A HERG‐like K+ channel in rat F‐11 DRG cell line: pharmacological identification and biophysical characterization. , 1996, The Journal of physiology.

[34]  D. Snyders,et al.  High affinity open channel block by dofetilide of HERG expressed in a human cell line. , 1996, Molecular pharmacology.

[35]  M. Sanguinetti,et al.  Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides. , 1996, Circulation research.

[36]  J. Hancox,et al.  A method for making rapid changes of superfusate whilst maintaining temperature at 37 degrees C. , 1996, Pflugers Archiv : European journal of physiology.

[37]  G. Robertson,et al.  HERG, a human inward rectifier in the voltage-gated potassium channel family. , 1995, Science.

[38]  M. Sanguinetti,et al.  A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.

[39]  J. Ballenger,et al.  Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients. , 1993, The Journal of clinical psychiatry.

[40]  P. Fouet,et al.  [Ventricular arrhythmia during fluvoxamine poisoning]. , 1993, Therapie.

[41]  J. Feighner,et al.  A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression. , 1989, International clinical psychopharmacology.

[42]  W. Wouters,et al.  Acute cardiac effects of fluvoxamine and other antidepressants in conscious rabbits. , 1983, Archives internationales de pharmacodynamie et de therapie.

[43]  J. C. Roos,et al.  Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine. , 1983, British journal of clinical pharmacology.